NetScientific buoyed by Vortex’s tech endorsement
The firm commercialises intellectual property (IP) through developing early and mid-stage healthcare firms
Company
EMV Capital
LON:NSCI
EMV Capital plc is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, the group invests in, manages, and strengthens early stage IP-rich companies.
424 stories · page 19 of 22
Archive
Proactive news round-up: Hayward Tyler, Akers Biosciences, MaxCyte ...
A glance at some of the stories on the Proactive newswire today
Vortex technology further endorsed in recent papers, says NetScientific
As reported last month, the firm has begun the commercial launch of its VTX1 Liquid Biopsy System, which offers a breakthrough in early cancer detection.
Forbidden Technologies hit by chief exec resgination
Some the biggest rises and falls in London at 12 noon: Beowulf, Duet Real Estate, Servision
NetScientific hails commercial launch of breakthrough cancer detection device
The official launch took place in San Francisco at the Molecular Medicine Tri Conference.
Investments and investor services
FTSE 100 shares end higher as Unilever seeks more shareholder value
FTSE 100 shares ended higher on Wednesday, as Unilever talked up a review to show more shareholder value and Lloyds Banking posted its highest profit in a decade
Archive
Proactive news round-up: Falcon takes flight
Also featured: AFC, Ferrum Crescent, Galileo, Kibo, Lansdowne Oil, Metal Tiger, Netscientific, Powerhouse, REM, ReNeuron, Tern
NetScientific hails award-winning scientist
Vortex Biosciences' Elodie Sollier-Christen received the 2017 Society award for Laboratory Automation and Screening Innovation.
Archive
Proactive news round-up: Vast Resources, Arian Silver, NetScientific ...
A glance at some of the stories on the Proactive newswire today
NetScientific announces new CEO for portfolio company Wanda
Wanda uses machine learning in place of conventional technologies, thus enabling clinicians to make more informed care decisions
NetScientific provides more backing for cancer immunotherapies developer
The transatlantic healthcare IP commercialisation group has upped its stake in PDS Biotechnology
Proactive news summary: Windar Photonics has the wind behind it
Companies covered: ANGLE, Berkeley Energia, Best of the Best, Deltex, Forbidden Technologies, Frontier IP, Iofina, Ironridge, ITM Power, LGO Energy, Netscientific, Redx, ServicePower, Strategic MineralsPLC
NetScientific shares gain as Vortex makes commercialisation progress
Vortex updated on progress with its CTC capture system
Vortex Bio gains FDA registration for Class 1 medical device
Vortex Biosciences, a provider of circulating tumor cell (CTC) capture systems, Thursday announced it has registered a Class I medical device with the US Food and Drug Administration and established a CE Mark for its proprietary CTC capture
NetScientific's Vortex Biosciences has new director
Neff has served in a number of leadership positions in healthcare companies
Proactive news highlights: Highlands, Metal Tiger, MySQUAR, Seeing Machines and more...
Friday's headline round up from the Proactive news desk.
NetScientific celebrates CE mark breakthrough for its ProAxsis unit
"This is a very proud day for everyone at ProAxsis," said Dr David Ribeiro, CEO of ProAxsis
NetScientific revitalised by focus on core portfolio
The group has ambitions to strengthen its transatlantic focus through organic and strategic growth